Clinical Trials Logo

Hemodialysis Catheter Infection clinical trials

View clinical trials related to Hemodialysis Catheter Infection.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT03425448 Not yet recruiting - Clinical trials for Hemodialysis Catheter Infection

Neutrolin Versus Heparin for Locking Hemodialysis Catheters

Start date: April 4, 2019
Phase: N/A
Study type: Interventional

Hemodialysis catheter related bacterial infections represent a major cause of mortality and morbidity in the hemodialysis population. Several locking agents had been tried with variable degree of success but not without side effects. Neutrolin catheter locking agent comprises of heparin,citrate and trauolidine that had been studied in a prospective study in Germany, and it demonstrated a very good result in terms of reducing the catheter related infections and thrombosis. This study is a multi-center, double-blind RCT comparing the hemodialysis catheter locking solution Neutrolin with heparin in reducing the rate of catheter related bacterial infection and thrombosis.